NorthStar Medical Radioisotopes has received a custom-built IBA Rhodotron TT 300-HR electron beam accelerator to its new Ac-225 Production facility, the organization announced recently. According to a release, the accelerator…
Promega announced recently that it has launched a wastewater testing kit that pairs its Maxwell HT chemistry with Ceres Nanosciences’ Nanotrap particles, an established technology for capturing and concentrating low-abundance…
JangoCell, a subsidiary of JangoBio, has entered into a distribution partnership for Captivate Bio’s culture media, balanced salt solutions, small molecules and other culture reagents, the company announced recently. “JangoCell…
Nimble Therapeutics has expanded its collaboration and executed a license agreement with Genentech, the company announced recently. According to a release, the two companies will work together on the discovery…
NorthStar Medical Radioisotopes is collaborating with Inhibrx, a biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, the company announced recently. According to a release, the…
Voximetry received 510(k) market clearance from the U.S. Food and Drug Administration for its Torch Dose Assessment for Radiopharmaceutical Therapy, the company announced recently. According to a release, Torch can…
Plumb Pharmaceuticals announced recently that it received an investment from the Winnow Fund earlier this year. The company did not reveal the investment amount. Plumb Pharmaceuticals is currently developing its…
Venture Investors and the State of Wisconsin Investment Board participated in a $100 million financing round for HistoSonics, which made the announcement today. The Minneapolis-based HistoSonics is a developer of…
Exact Sciences’ announced today its initial clinical validation data for its Profile for the Omission of Local Adjuvant Radiotherapy (POLAR). According to a release, POLAR is the first genomic signature…
NorthStar Medical Radioisotopes has broken ground on a new facility that will house a planned contract development and manufacturing business unit called Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), the…
